TY  - GEN
AU  - Tcheng,J E
AU  - Kereiakes,D J
AU  - Lincoff,A M
AU  - George,B S
AU  - Kleiman,N S
AU  - Sane,D C
AU  - Cines,D B
AU  - Jordan,R E
AU  - Mascelli,M A
AU  - Langrall,M A
AU  - Damaraju,L
AU  - Schantz,A
AU  - Effron,M B
AU  - Braden,G A
TI  - Abciximab readministration: results of the ReoPro Readministration Registry
SN  - 1524-4539
PY  - 2001///0913
KW  - Abciximab
KW  - Angioplasty, Balloon, Coronary
KW  - adverse effects
KW  - Antibodies
KW  - blood
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Aspirin
KW  - Coronary Disease
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Hemorrhage
KW  - etiology
KW  - Heparin
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Platelet Aggregation
KW  - drug effects
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Postoperative Complications
KW  - prevention & control
KW  - Registries
KW  - statistics & numerical data
KW  - Thrombocytopenia
KW  - diagnosis
KW  - Treatment Outcome
KW  - United States
KW  - Vascular Patency
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/hc3301.094533
ER  -